title: Comparison of composition of atherosclerotic plaques in saphenous veins used as aortocoronary bypass conduits with plaques in native coronary arteries in the same men.
abstract: This study describes quantitatively the components of atherosclerotic plaques in saphenous vein grafts used for aortocoronary bypass and compares the findings with the plaques in the native coronary arteries in the same men. A total of 607 five-mm segments of saphenous veins and 797 five-mm segments of native coronary arteries were examined by computerized planimetric technique in 19 men, aged 39 to 82 years (mean 61), who had survived bypass operation for > 1 year. Comparison of the mean percentages of the plaque components in saphenous vein grafts in place for 14 to 26 months with those of the native coronary arteries revealed significant differences: cellular fibrous tissue, 86 vs 7%; dense fibrous tissue, 13 vs 82%; p < 0.05. As survival time after the bypass operation increased, composition of the plaques in the saphenous veins changed so that by approximately 80 months the amounts of cellular and dense fibrous tissue in both saphenous vein grafts and native coronary arteries were similar: 10 vs 16%, and 75 vs 71%; p = not significant. Thus, by about 7 years after a coronary bypass operation the composition of plaques in saphenous vein grafts is similar to that in the native coronary arteries of the same patients.
authors.affiliation: Pathology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.
authors.forename: S L
authors.initials: SL
authors.lastname: Mautner
authors.forename: G C
authors.initials: GC
authors.lastname: Mautner
authors.forename: S A
authors.initials: SA
authors.lastname: Hunsberger
authors.forename: W C
authors.initials: WC
authors.lastname: Roberts
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001161:Arteriosclerosis / Q000378:metabolism / Q000473:pathology*; D002114:Calcinosis / Q000473:pathology; D002423:Cause of Death; D002784:Cholesterol / Q000032:analysis; D003251:Constriction, Pathologic / Q000473:pathology; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000378:metabolism / Q000473:pathology*; D005110:Extracellular Space; D005347:Fibroblasts / Q000473:pathology; D005487:Foam Cells / Q000473:pathology; D006470:Hemorrhage / Q000473:pathology; D006801:Humans; D008214:Lymphocytes / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D012501:Saphenous Vein / Q000473:pathology* / Q000637:transplantation*; D015996:Survival Rate; D013927:Thrombosis / Q000473:pathology; D013997:Time Factors
chemical_list: D002784:Cholesterol